In agreement with previous observations in which higher levels of p-MEK5 were correlated with T3–4, N1–2 and M1 carcinomas, our results suggest that ERK5 signalling pathway could potentially be used as a biomarker, or as a prognostic factor for colon cancer progression.16 This evidence concerns the gene MAP2K5 and carcinoma.